J.P. Morgan increased its target price on Tesla Motors Inc. (NASDAQ:TSLA) to $164, increased its estimates and set a “neutral” rating. The firm noted the Gigafactory should help cut battery costs. Tesla Motors Inc. (NASDAQ:TSLA) dropped -3.06% to $244.81 yesterday on volume of 24,825.00 shares. The intra-day range of the stock was $242.55 – $252.68….
BlackBerry Ltd (NASDAQ:BBRY) is planning to launch its recently unveiled low-cost smartphone, the Z3, in Indonesia first, which is a promising market. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -4.67% in last session and finished the day at $10.00. Traded volume was 6,025.00 shares in the last session and the average volume of the stock remained…
A burst pipe at AT&T, Inc. (NYSE:T)’s downtown Akron switching office knocked out 911, land line and cellular phone service to many customers in Medina, Portage, Stark and Summit counties Tuesday evening into Wednesday morning. AT&T, Inc. (NYSE:T) belongs to Technology sector. Its net profit margin is 13.00% and weekly performance is 0.48%. On last…
BlackBerry Ltd (NASDAQ:BBRY) plans to wade into the transportation industry with new technology that will help shippers keep tabs on their freight. The Waterloo, Ont.-based company unveiled the foundation of its Internet of Things platform on Wednesday at the Consumer Electronics Show in Las Vegas, marking the first step towards building a service BlackBerry believes…
BlackBerry Ltd (NASDAQ:BBRY) has always been known for their enterprise security and it sounds like it may be a good idea to keep one around in case of emergency. According to a Wall Street Journal report, Inside BlackBerry has the details, Sony employees found some BlackBerry phones after hackers shut the company down. BlackBerry Ltd…
On Dec. 18, Curis, Inc. (NASDAQ:CRIS) announced that the first patient has initiated treatment with CUDC-907 in a Phase 1 clinical trial in patients with advanced or relapsed solid tumors, including hormone receptor positive (HR+)/ HER2-negative breast cancer or midline carcinoma with certain NUT gene rearrangements. CUDC-907 is an oral, dual inhibitor of histone deacetylase…
